Completed NA INTERVENTIONAL 2-arm NCT05975879

A Study of the Feasibility of Using the Dietary Supplement ARTNEO in Patients With Osteoathritis

Multicenter, Prospective, Double-blind, Placebo-controlled, Randomized Study of the Feasibility of Using the Dietary Supplement ARTNEO®, Capsules for Oral Administration in Patients With Stage II-III Primary Knee Osteoarthritis

Sponsor: NPO Petrovax

Conditions Knee Arthritis Knee Discomfort Knee Osteoarthritis Knee Pain Chronic Knee Pain Swelling Osteoarthritis Osteoarthritis, Knee

Interventions Placebo undenaturated collagen type II, methylsulfonylmethane, boswellia serrata, vitamin D3 (cholecalciferol), vitamin C (ARTNEO)

Updated 4 times since 2023 Last updated: Jul 31, 2024 Started: May 31, 2022 Primary completion: Feb 28, 2023 Completion: Apr 17, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05975879, this NA trial focuses on Knee Arthritis and Knee Discomfort and remains completed. Sponsored by NPO Petrovax, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NPO Petrovax

Data source: NPO Petrovax

For direct contact, visit the study record on ClinicalTrials.gov .

A Study of the Feasibility of Using the Dietary Supplement ARTNEO in Patients With Osteoathritis

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials